Alnylam Pharmaceuticals (ALNY) PT Lowered to $111 at Stifel
Tweet
Share
E-mail
Get Alerts ALNY Hot Sheet
Price: $278.09 -1.64%
Rating Summary:
29 Buy, 12 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 1 | Down: 0 | New: 0
Rating Summary:
29 Buy, 12 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 1 | Down: 0 | New: 0
Join SI Premium – FREE
Stifel analyst Paul Matteis lowered the price target on Alnylam Pharmaceuticals (NASDAQ: ALNY) to $111.00 (from $117.00) while maintaining a Buy rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- PebbleBrook Hotel Trust (PEB) PT Raised to $20.25 at Stifel after Mgmt Meetings
- BHP Billiton Ltd. (BHP:AU) (BHP) PT Raised to AUD67 at CLSA
- PolyPeptide Group AG (PPGN:SW) PT Raised to CHF45 at UBS
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
StifelSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
